ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2016

Abstract Number: 2874

CD16+monocytes Are Enriched and Functionally Exacerbated in Driving B Cell Activation Under Systemic Lupus Erythematosus Condition

Huaqun Zhu1, Yin Su2, Fanlei Hu3 and Liling Xu3, 1Department of Rheumatology and Immunology/Clinical Immunology Center, Peking University People's Hospital, Beijing, China, 2Department of Rheumatology and Immunology,Clinical Immunology Center, Peking University People's Hospital, Beijing, China, 3Peking University People's Hospital, Beijing, China

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2016

Date of first publication: September 28, 2016

Keywords: B cells, monocytes and pathogenesis, SLE

Session Information

Date: Tuesday, November 15, 2016

Title: Systemic Lupus Erythematosus – Human Etiology and Pathogenesis - Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

  • Background/Purpose: Systemic lupus erythematosus(SLE) was an autoimmune disease characterized by extensive B cell activation and autoantibody production. Human peripheral monocytes could be categorized into three subsets based on differential expression levels of CD14 and CD16: the classical monocytes (CM, CD14++CD16-), the intermediate monocytes (IM, CD14++CD16+) and the nonclassical monocytes (NCM, CD14+CD16++). NCM and IM were collectively addressed as CD16+monocytes. The three subsets had been described to demonstrate diffierent functions in inflammatory process. However, their effects on B cell response in SLE were not well studied.The aim of this study was to determine the frequencies of these subsets and investigate their possible roles in B cell activation and differentiation under SLE condition.

  • Methods: The frequencies of monocyte subsets in the peripheral blood of healthy donors (HC) and patients with SLE were determined by flow cytometry (FACS). Monocyte subsets were sorted and co-cultured with CD19+ B cells. B cell were co-cultured for different subsets detection by FACS, while the supernatant were collected for IgG, IgA and IgM detection by enzyme-linked immunosorbent assay (ELISA). The function of monocyte subsets on B cell was defined as the ratio of the effects of monocyte subsets co-cultured with B cell versus the effects of B cell cultured alone. 

  • Results: CD16+monocytes were obviously expanded in SLE, while CM were significantly reduced. Compared to HCs, monocyte subsets in patients with SLE demonstrated different phenotypes about HLA-DR, CD163, CD80, CD86, CX3CR1 and CCR5 expression. CD16+monocytes induced CD19+B cells to differentiate into memory B (MB) and plasma B (PB) cells but inhibited the generation of regulatory B (Breg) cell in HC donors. However, both PB response and Breg differentiation induced by CD16+monocytes were exacerbated in patients with SLE. IgG secretion from CD19 positive B cells was increased when cocultured with CD16+monocytes in HCs, which was significantly enhanced when co-cultured with CD16+monocytes in patients with SLE. IgA and IgM responses were differentially regulated by monocyte subsets from SLE and HC, respectively. Compared to CM, CD16+monocytes extensively promoted the expansion of IL-17A- and IL-10- producing B cells, suggesting the preferable role of CD16+monocytes in cytokines secretion from B cells in HCs,. In comparison to HCs, the generation of IL-17A-producing B cells in patients with SLE were significantly elevated in the presence of CD16+monocytes, in which the generation of IL-10 producing B cells were obviously attenuated .

  • Conclusion: CD16+monocytes was enriched and shared different cell-surface marker profiles in SLE. These cells played a predominant role in orchestrating B cell activation and differentiation in SLE.


Disclosure: H. Zhu, None; Y. Su, None; F. Hu, None; L. Xu, None.

To cite this abstract in AMA style:

Zhu H, Su Y, Hu F, Xu L. CD16+monocytes Are Enriched and Functionally Exacerbated in Driving B Cell Activation Under Systemic Lupus Erythematosus Condition [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/cd16monocytes-are-enriched-and-functionally-exacerbated-in-driving-b-cell-activation-under-systemic-lupus-erythematosus-condition/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cd16monocytes-are-enriched-and-functionally-exacerbated-in-driving-b-cell-activation-under-systemic-lupus-erythematosus-condition/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology